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PERBANDINGAN KADAR JANGKITAN MELALUI ALIRAN DARAH YANG 
BERKAITAN DENGAN KATETER SEBELUM DAN SELEPAS 
PELAKSANAAN BUNDEL KATETER LALUAN PUSAT VENA DI HOSPITAL 
USM. 
ABSTRAK 
Pengenalan: Jangkitan melalui aliran darah yang berkaitan dengan kateter boleh 
menyebabkan sepsis dan membawa maut. Ia juga menyebabkan penigkatan kos rawatan. 
Langkah pencegahan seperti pelaksanaan bundel kateter laluan pusat vena telah terbukti 
dapat mengurangkan kadar jangkitan. Matlamat kajian ini adalah untuk mengetahui kesan 
pelaksanaan bundel ini ke atas kadar kelaziman insiden jangkitan melalui aliran darah 
yang berkaitan dengan kateter dan ejen mikroorganisma penyebab jangkitan di Hospital 
USM. 
Kaedah: Ini adalah kajian kohort ke atas pesakit yang mempunyai kateter laluan pusat di 
Hospital USM daripada April 2016 sehingga Disember 2017. Pesakit yang berumur 18 
tahun keatas yang memenuhi kriteria definisi jangkitan melalui aliran darah yang 
berkaitan dengan kateter adalah termasuk dalam kajian ini, manakala pesakit yang telah 
mempunyai kateter saluran darah adalah terkecuali. Data dari April 2016 hingga 
Disember 2016 adalah dijadikan sebagai data pra-intervensi. Manakala intervensi 
dilakukan dari Januari 2017 hingga Mac 2017 dan diikuti dengan pemerhatian selepas 
intrevensi dari April hingga Disember 2017. Pelaksanaan bundel ini adalah berdasarkan 
garis panduan Pusat Kawalan dan Pencegahan Penyakit(CDC) tahun 2009. Maklumat 
pesakit diperolehi daripada rekod pesakit dan juga system informasi makmal. Keputusan 
xi 
kajian dianalisa secara diskriptif dan menggunakan analisa statistic SPSS versi 24 dan 2-
point Poison Rate. 
Keputusan: Sejumlah 126 kes CRBSI telah direkodkan yang melibatkan 57% (n=72) 
and 43% (n=54) pesakit semasa sebelum dan selepas intervensi.  Kadar insidens lazim 
ialah 0.88 per 100 admission-days sebelum intervensi, berbanding 0.39 per 100 
admission-days selepas intervensi. Keputusan ini adalah signifikan secara statistik 
(p<0.001). Kadar incidence CRBSI berdasarkan kiraan berdasarkan 1000 catheter-days 
ialah 18.1 (95% confidence interval: 13.3-22.0) per 1000 catheter-days. Mikroorganism 
Gram-positif adalah lebih dijumpai semasa pre-intervensi berbanding dengan Gram-
negatif selepas intervensi. Mikroorganisma yang paling kerap diisolat ialah 
Staphylococcus aureus (50%, n=11), Enterococcus fecalis (18.2%, n=11), and 
Pseudomonas aeruginosa (15.4%, n=4). Kadar kepatuhan kepada bundel ialah dalam 
lingkungan 85-100%.  
 
Kesimpulan: Kadar insidens CRBSI menurun selepas pelaksanaan bundel kateter laluan 
pusat vena. Kadar keberkesanan pelaksanaan kepatuhan kepada bundel ini juga sangat 
baik. Mikroorganisma Gram-negatif adalah lebih banyak ditemui selepas pelaksanaan 
bundel ini.   
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COMPARISON OF CATHETER RELATED BLOODSTREAM INFECTION 
RATE BEFORE AND AFTER THE IMPLEMENTATION OF CENTRAL 
VENOUS CATHETER CARE BUNDLE IN HOSPITAL USM. 
ABSTRACT 
 
Introduction: Catheter related bloodstream infection (CRBSI) increases risk of 
bloodstream infections and sepsis-related death which leads to longer hospitalisation and 
created significant medical and economic burden. The implementation of the CVC Care 
Bundle has shown to decrease the incidence of CRBSIs worldwide. This study aimed to 
analyse the incidence rate of CRBSI following implementation of CVC Care Bundle in 
Hospital USM.  
 
Methodology: This was a cohort study conducted in all patients admitted to Hospital 
USM within April 2016 till December 2017 who had CVC inserted on them. Patient who 
aged more than 18 years old and newly admitted patient for various indication of 
catheterisation were included in the study, whereas patients who already had other central 
venous devices were excluded in the study. Data of CRBSI cases from April 2016 to 
December 2016 was taken as pre-intervention data. Intervention was done for three 
months from January 2017 to March 2017 followed by post-intervention from April 2017 
to December 2017. Implementation that was done include strict practices of CVC Care 
Bundle based on CDC guidelines in year 2009. Patient’s information was obtained from 
medical record and laboratory information system. The results were presented as 
descriptive and statistically analysed using SPSS version. Comparison of incidence rate 
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of CRBSI was done using 2-Sample Poisson Rate as a p<0.05 was considered statistically 
significant. 
 
Result: A total of 126 cases of CRBSI were documented which consist of 57% (n=72) 
and 43% (n=54) patients pre and post-intervention respectively.  The incidence rate of 
CRBSI was 0.88 per 100 admission days, compared to 0.39 per 100 admission days 
during post-intervention. The result was statistically significant (p <0.001). The incidence 
of CRBSI based on 1000 catheter days was of 18.1 (95% confidence interval: 13.3-22.0) 
per 1000 catheter-days. Gram-positive organism was the most common causative 
organism during pre-intervention whereas Gram-negative organism dominating during 
post-intervention. The most common organisms isolated were Staphylococcus aureus 
(50%, n=11), Enterococcus fecalis (18.2%, n=11), and Pseudomonas aeruginosa (15.4%, 
n=4). The compliance rates to CVC care bundle were in the range 85-100%.  
 
Conclusion: Incidence rate of CRBSI reduced following the implementation of CVC 
Care Bundle. Compliance rates towards CVC care bundle were excellent. Gram-negative 





Central venous catheters (CVCs) are commonly inserted in critically ill patients for 
various indications such as administration of fluids, medications, blood products nutrition 
(TPN) and monitoring hemodynamic status. European Prevalence of Infection in 
Intensive Care (EPIC) study in 1995 has reported about 78% of critically ill patients had 
intravenous catheter (Vincent et al., 1995). The presence of this CVC may cause 
complications such as arterial puncture, bleeding, occlusive thrombosis, bloodstream 
infections and sepsis-related death. 
Catheter related bloodstream infection (CRBSI) is among the problematic health care 
associated infection (HCAI). CRBSI associated with significant morbidity, increased 
duration of hospital stay and furthermore increases the usage of broad-spectrum 
antibiotics which later can promotes bacterial resistance (Dimick et al., 2001). The 
medical and economic burden of CRBSI is huge, which estimated excess healthcare cost 
of $18, 000 (Zhou et al., 2015). The economic impact of each CRBSI episode is 
significant, with the Centers for Disease Control and Prevention (CDC) estimating direct 
costs ranging from $5,734 to $22,939 per episode (Dumyati et al., 2014). 
CRBSI lead to longer hospitalisation and additional expenditures, CRBSI-related ICU 
costs increase, regardless of medical specialties as reported by E.Tacconelli et al, 2009. 
Indeed, Nakamura et al. reported that the estimated additional mean costs of each case of 
CRBSI in Japan were $57,090 (Nakamura et al., 2015). Thus, strategies are needed to 
prevent these infections include the implementation of the central venous catheter (CVC) 
bundle as this infection causes substantial morbidity, mortality and incurs high costs. 
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Central venous catheter (CVC) Care Bundle is one of the preventive strategies that was 
implemented by CDC in 2009 with the aim is to prevent these infections. The central line 
bundle is a group of evidence-based interventions that has shown to reduce the risk of 
central line-associated bloodstream infection (O'grady et al., 2011; Zhou et al., 2015).  
CVC Care Bundle incorporates evidence-based science into practices, and is 
recommended in international CRBSI guideline. The bundle involves several 
components. Those include educating and training healthcare personnel who insert and 
maintain catheters; using of maximal sterile barrier precautions during central venous 
catheter insertion; the use of a > 0.5% chlorhexidine skin preparation with alcohol for 
antisepsis and also care for maintenance of the catheter (O'grady et al., 2011). 
The bundles were shown to reduce the rates of CVC related infections for more than a 
decade. Recent study had demonstrated that consistent application of evidence-based 
practices can lead to significant, sustained reductions in CLABSI rates. A study was 
conducted  by Salama et al. between January 2010 and February 2012 demonstrated that 
implementation of CVC post-insertion bundle was associated with a reduction in 
CLABSI /1000 central line days from 14.9 to 11.08 infections in intensive care unit of 
general teaching hospital in Kuwait (Salama et al., 2016).  
The use of this bundle has been shown to decrease the incidence of CRBSIs worldwide 
(Khalid et al., 2013; Pronovost et al., 2010). A multimodal intervention done by Ghinwa 
Dumyati et al. (Dumyati et al., 2014)  in 2014, which included engagement and education 
of nursing staff on an evidence-based bundle for CVC insertion and maintenance, along 
with measurement and feedback of CRBSI rates and a review of CRBSI cases, resulted 
in a sustainable reduction in CRBSI rates outside the ICU across 6 diverse hospitals. 
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One study conducted by Rosenthal et al. addressed that the education, performance 
feedback, and outcome and process surveillance of CLABSI rates significantly improved 
infection control adherence, reducing the CLABSI incidence by 54% and the number of 
CLABSI-associated deaths by 58% in INICC hospitals during the first 2 years (Rosenthal 
et al., 2010).  
A landmark study included 103 ICUs in Michigan in 2006 by Pronovost et al. 
demonstrated that strict adherence to a bundled practice of hand hygiene, full barrier 
precautions, chlorhexidine skin antisepsis, femoral site avoidance, and early removing 
unnecessary central line could dramatically reduce the rate of CRBSI to nearly 0% 
(Pronovost et al., 2006). This rate of zero was also sustained at the 18-month follow-up. 
A similar study was conducted by Schulman et al. in 18 neonatal ICUs in New York 
resulted overall state-wide rates of CRBSI declined from 6.4 cases/1000 catheter-days to 
2.1cases/1000 catheter-days by establishing a central line maintenance checklist, using 
hand hygiene, sterilizing skin with chlorhexidine and removing unnecessary catheters 
(Schulman et al., 2011).  
Son CH et al. in 2011 demonstrated that central line-associated bloodstream infection 
(CLABSI) rates outside the ICU are similar to those in the ICU, but the number of non-
ICU patients at risk is substantially larger, leading to a greater burden of infection 
compared with the ICU setting.  
Compliance with the bundle was a protective factor against the development of CRBSI 
with staff adherence to the bundle in ICUs in Colombia was over 80% as reported by 
Osorio et al. (Osorio et al., 2013). However the overall compliance of bundle in ICUs at 
regional teaching hospital in Taiwan by study Hung-Jen et al. was much lower; was only 
50.3% (Tang et al., 2014). Compliance to maximal sterile barrier was low due to 
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emergency condition. Therefore we introduced the CVC kit with checklist and enough 
sterile drapes to improve compliance among healthcare-workers. 
Reducing the number of CRBSI cases can be translated to reduction of the hospital 
acquired infection and the final outcome is the reduction in the hospital expanses. Apart 
from sophisticated devices, other important measures in preventing CRBSI are the 
education and the compliance among healthcare-workers towards the CVC Care Bundle. 
The effort to reduce the number of CRBSI cases should be multidisciplinary, involving 
healthcare professionals’ example doctors who order and insert the catheters, staff nurses, 
medical attendants who maintain and taking care of the catheters and infection control 
personnel. 
1.2 Definition of CRBSI 
A CVC was defined as an intravascular catheter terminating at or close to the heart or in 
a great vessel and used for infusion, withdrawal of blood, or hemodynamic monitoring 
(Horan et al., 2008). CRBSI was defined according to Centers for Disease Control and 
Prevention/National Healthcare Safety Network surveillance criteria as 
bacteremia/fungemia in a patient with an intravascular catheter (the line was in use during 
the 48-hour period before the development of the bloodstream infection) with positive 
blood culture (central and peripheral fulfilled requirement based on time to positivity), 
clinical manifestations of infection (ie, fever, chills, and/or hypotension), and no apparent 
source for the bloodstream infection except the catheter (Dimick et al., 2001; Horan, 
2004b; Horan et al., 2008; O'grady et al., 2011). CRBSI rate was calculated using 
denominator of cases per 1000 catheter-days (Horan, 2004b). However the incidence 
rates can be calculated by other method that is based on 100 admission days (Control and 
Prevention, 2012). 
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1.3 Types of central venous catheter and indication of central venous catheterisation 
There are four types of central venous catheter available include non-tunnelled, tunnelled, 
peripherally inserted and totally implantable catheters. Catheters can be inserted through 
a peripheral vein or a proximal central vein, most commonly the internal jugular, 
subclavian, or femoral vein.  
Antimicrobial agents, such as antiseptics or antibiotics coated onto or incorporated into 
the catheter polymer, as a way to prevent bacterial colonisation and the development of 
CRBSI. Some of the antimicrobial CVC available are silver, chlorhexidine and silver 
sulfadiazine, benzalkonium chloride, and minocycline rifampicin. A relatively large 
number of trials have been carried out on the chlorhexidine silver sulfadiazine CVC and 
many have achieved a significant reduction both in microbial colonisation of the catheters 
and in CRBSI (Heard et al., 1998; Maki et al., 1997).  
The most extensively studied antimicrobial CVCs are those coated with chlorhexidine–
silver sulfadiazine (CSS). These antiseptics act synergistically against microorganisms. 
Chlorhexidine disrupts the microbial cytoplasmic membrane, thus facilitating the uptake 
of silver ions, which subsequently bind to the DNA and prevent replication. These CVCs 
were originally marketed with both antimicrobial agents on the external surface only and 
remained effective for up to 15 days (Elliott, 2007). A systematic review and meta-
analysis of antimicrobial central venous catheters in adults reported that use of 
chlorhexidine–silver sulfadiazine and minocycline–rifampicin CVCs were significantly 
reduces catheter colonisation and incidence of CRBSI (Casey et al., 2008). 
Impregnating the surface of the catheter with antiseptic or antimicrobial substances (such 
as chlorhexidine and silver sulfadiazine) reduces CRBSI. A Cochrane review of the 
effectiveness of this approach for reducing CRBSI in adults which included 56 studies 
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and 16 512 catheters with 11 different types of impregnation, bonding, or coating (Lai et 
al., 2013). The study reported that patient who had impregnated catheters had lower rates 
of CRBSI (absolute reduction in CRBSI was 2%). Thus, catheter impregnation reduced 
the risk of catheter related bloodstream infections and catheter colonisation.  
The draft epic 3 guidelines recommend that impregnated lines should be used only in 
patients who are expected to have a catheter in place for more than five days and in units 
where the CRBSI rate remains high (Loveday et al., 2013). Von Eiff et al. reported that 
the catheters remain effective for up to only 15 days in situ (Von Eiff et al., 2005). 
Furthermore, the chlorhexidine resistance has not been reported yet with the clinical use 
of these devices (Rupp et al., 2005; Von Eiff et al., 2005). Instead, the problem has been 
identified with the catheters was hypersensitivity reactions. 
The indications for central venous catheterisation include access for giving drugs and 
fluids, extracorporeal blood circuits like renal replacement therapy, plasma exchange and 
total parenteral nutrition, and haemodynamic monitoring and interventions like central 
venous pressure, central venous blood oxygen saturation, pulmonary artery pressure, and 
for repeated blood sampling. Most of the contraindications to central venous 
catheterisation are thrombocytopenia, vessels thrombosis, stenosis, or disruption, and any 
infection overlying insertion site. 
1.4 Risk factors for CRBSI 
Associated risk factors of CRBSI were duration of central venous catheter use (O'grady 
et al., 2011; Pronovost et al., 2006) length of hospitalization time, long-term indwelling 
central venous catheter, and insertion of central venous catheter in intensive care unit; use 
catheter for parenteral nutrition and administration of blood products, underlying disease 
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such as neutropenia and diabetes mellitus, sepsis at insertion and administration of one or 
more antibiotics before insertion (Almuneef et al., 2006).  
The higher the risk of catheter-related infection would be expected when the longer used 
of CVC. Indeed, the duration of catheterisation was important risk factor in the 
development of CRBSI in some studies (Arruda et al., 1997; Tacconelli et al., 2009; Tan 
et al., 2007). However, there were studies showed no relationship between prolonged 
catheterisation and incidence of infection (Eyer et al., 1990; Gowardman et al., 1998). 
The CRBSI cases had a significant on duration of catheter days and lengths of hospital 
stays but no differences on hospital mortality (Jaroen Cheewinmethasiri et al., 2014). 
The site for CVC insertion that was associated with the higher risk of CRBSI remained 
controversial. No randomised trial had satisfactorily compared infection rates of CRBSI 
for catheters placed in jugular, subclavian and femoral area. Merrer  et al. performed a 
randomized controlled trial comparing complications of femoral and subclavian venous 
catheterisation in critically ill patients and found that femoral catheterisation was 
associated with a higher incidence of clinical sepsis with or without bloodstream infection 
which did not reach statistical significance (p=0.07) (Merrer et al., 2001).  
CDC Guidelines for Prevention of Intravascular Catheter-Related Infections in 2011 
recommended avoid using of the femoral vein for central venous access in adult patients 
whereas avoid the subclavian site in hemodialysis patients as it can lead to subclavian 
venous stenosis (Goetz et al., 1998; O'grady et al., 2011; Parienti et al., 2008). The 
evidence for avoiding femoral catheter was based on higher risk for deep venous 
thrombosis and higher colonization rates (Goetz et al., 1998; Trottier et al., 1995). 
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The presence of multiple lumen of CVC increased the risk of CRBSI. A study by  
Almuneef et al. reported that the presence of multiple lumen of CVC increased the risk 
of CRBSI almost 10-fold in their PICU (Almuneef et al., 2006). The frequent sampling 
through the lines might increase the opportunity for introduction of microorganisms into 
the catheters.  
Catheters which placed under emergency situations, during which optimal aseptic 
conditions had been significantly associated with higher risk of catheter-related infection 
compared to elective situation (Goetz et al., 1998; Mermel et al., 1991). Patient with renal 
problem were at risk of CRBSI, particularly patients undergoing hemodialysis due to 
uraemia, vascular access, and the combination of surgery and immunosuppressive therapy 
(Rojas et al., 2013). 
1.5 Pathogenesis of CRBSI 
There are four common routes for contamination of catheters: migration of skin 
organisms at the insertion site into the cutaneous catheter tract and along the surface of 
the catheter with colonization of the catheter tip; this is the most common route of 
infection for short-term catheters; direct contamination of the catheter or catheter hub by 
contact with hands or contaminated fluids or devices; less commonly, catheters might 
become hematogenously seeded from another focus of infection; and rarely, infusate 
contamination might lead to CRBSI (Crnich and Maki, 2002). Extraluminal colonisation 
from the skin colonised the line during insertion or migrated along the catheter tract which 
could occur early after line insertion. 
The adherence properties of microorganism are important in the pathogenesis of CRBSI. 
Stahylococcus aureus as example can adhere to the host protein such as fibrinogen and 
fibronectin that commonly present on catheter by expressing the clumping factors that 
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bind to protein adhesins (Mehall et al., 2002). Furthermore the proteins facilitate the 
adherence of microorganisms such as coagulase negative staphylococci, S.aureus, 
Pseudomonas aeruginosa and Candida species of an extracellular polymeric substance 
of exopolysaccharide that form a microbial biofilm layer (Donlan, 2002). This biofilm, 
allow them to battle with host defence mechanism and protects them from 
chemotherapeutic agents and opsonophagocytosis and furthermore make them less 
susceptible to antimicrobial agents (Donlan, 2000; Farber et al., 1990). 
1.6 Incidence of CRBSI 
The prevalence of CRBSI in Malaysia was around 3.2-9.43 per 1000 catheter days 
reported by Sulong et al. in 2008, whereas in a study conducted at ICU Hospital UKM; 
overall rate was 6.4 per 1000 catheter days (Sulong et al.). However, the prevalence was 
much lower in developed countries at 1.8- 5.2 per 1000 catheter-days (Daniels and Frei, 
2013). In Europe, the rate of catheter-related bloodstream infections in intensive care 
units (ICUs) was between 1- 4.2 per 1000 catheter days (Almuneef et al., 2006). 
A multimodal intervention done by Dumyati et al. (Dumyati et al., 2014)  in 2014, which 
included engagement and education of nursing staff on an evidence-based bundle for 
CVC insertion and maintenance, along with measurement and feedback of CRBSI rates 
and a review of CRBSI cases, resulted in a sustainable reduction in CRBSI rates outside 
the ICU across 6 diverse hospitals. 
However there were several studies reported of higher rate of CRBSI. Study by Almuneef 
et al. in 2005 at PICU of King Abdulaziz Medical City (Riyadh) reported incidence rate 
of CRBSI 20.06 per 1000 catheter-days (Almuneef et al., 2006). Another study was 
conducted  by Salama et al. between January 2010 and February 2012 demonstrated that 
implementation of CVC post-insertion bundle was associated with a reduction in 
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CLABSI /1000 central line days from 14.9 to 11.08 infections in intensive care unit of 
general teaching hospital in Kuwait (Salama et al., 2016).  
There were various reports from developed and developing countries with variable rates 
(Khuri-Bulos et al., 1999; Stover et al., 2001; Yogaraj et al., 2002). This variability 
depends on unit-related parameters such as sample size and settings, patient’s 
comorbidities such as severity and type of illness, and catheter-related parameters such 
as type of catheter, site (route), conditions under which the catheter was inserted whether 
emergent of elective insertion, skill of person inserted the catheter and finally type of 
infusate and apparatus used. France presented the lowest incidence rate of CRBSI among 
the industrialised countries which was about 0.9 per 1000 catheter days (Group, 2009). 
1.7 Aetiological agent of CRBSI 
Most CRBSIs come from either the patient’s skin or the hands of medical personal, so 
that many literatures note that staphylococci, specifically S.aureus and S.epidermidis are 
the most common organism implicated in CRBSIs (Hooven and Polin, 2014; Sengupta et 
al., 2010). These organisms are able to colonise the catheter and difficult to treat because 
easily resistant to systemic antibiotic as they embedded themselves in a biofilm (Deva et 
al., 2013).  
However the causative etiological agents of CRBSI in other countries like Taiwan and 
China was reporting increase of Gram-negative bacteria isolated (Tao et al., 2011; Wu et 
al., 2006). A study was done by Tan et al. (Tan et al., 2007) reported the most common 
organism was Gram-negative organism with the percentage of 80.5% and the most 
common organism isolated was Klebsiella pneumoniae (38.9%). 
A 3-year prospective study by Lorente et al. in intensive care unit (ICU) of the Hospital 
Universitario de Canarias (Tenerife), between 1 May 2000 and 30 April 2003 reported a 
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total of 53 microorganisms were responsible for the 53 CRBSI cases, of which 38 
(71.70%) were Gram-positive bacteria, 12 (22.64%) were Gram-negative bacteria and 3 
(5.66%) were yeasts (Lorente et al., 2005). In addition, a report of CRBSI from Spain had 
also shown the same predisposition that Gram-positive bacteria were higher in the 
proportion compared to other microorganism (Rodríguez-Créixems et al., 2008). 
1.8 Clinical presentations and complication of central venous catheterisation. 
Clinical signs for CRBSI are not specific.  Fever and chills are the most sensitive clinical 
finding but is not specific. The presence of inflammation or pus at the catheter exit site is 
more specific but less sensitive. Furthermore, local catheter inflammation and phlebitis 
could exist in the absence of CRBSI (Walshe et al., 2002). Therefore physician consider 
a diagnosis of CRBSI in patients with signs of systemic infection in the absence of other 
identifiable source.  
Despite the benefits of central venous lines to patients, more than 15% of patients were 
developed catheter related complications. The use of antimicrobial CVCs needs to be 
carefully decided as the complications related to central venous catheters are common 
and may cause serious morbidity and mortality. Complications are divided into immediate 
and delayed, then subdivided into mechanical, embolic, and infectious. Air embolism 
may occur at any point during the lifetime of line and can be related to poor technique 
during line insertion, use of the line, or line removal.  
The risks of mechanical lesions include arterial puncture, pneumothorax, cardiac 
tamponade, or nerve lesions and thrombotic complication with each CVC. One of the 
most frequently reported complications of CVC insertion is arterial puncture (Yilmazlar 
et al., 1997). Incidence of pneumothorax has been reported to occur in 0.5% to 4% of the 
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insertions (Plewa et al., 1995), but the incidence was lower in other study by Tyburski et 
al. (Tyburski et al., 1993). 
The risk of catheter-related sepsis was be increased when the catheter was thrombosed 
(Timsit et al., 1998) . Rate of catheter related thrombi and CRBSI in cancer patients was 
reported more than 50% (Wu et al., 1999). The risk of getting CRBSI in patients with a 
CVC was reported to range between 1 and 10% (Adal and Farr, 1996). Incidence of 
infection as the complication of indwelling catheters was reported approximately 5.3 per 
1,000 catheter days and an attributed mortality of 18% (O'grady et al., 2011). 
1.9 Diagnosis 
Catheter related infection was suspected in a patient with an intravascular catheter (the 
line was in use during the 48-hour period before the development of the bloodstream 
infection) when any sign of local infection (induration, erythema, heat, pain, purulent 
drainage) and signs of systemic infection (fever, chills, and/or hypotension), with no 
apparent source of bacteremia except the catheter, and with the microbiological evidence 
that the catheter was the source of infection 
Culture of the same organism was isolated both from the catheter segment and peripheral 
blood with the differential period of CVC culture versus peripheral blood culture 
positively of more than two  hours, whether a positive semiquantitative (>15 Colony 
forming unit (CFU)/catheter segment) or by quantitative (>103 CFU/catheter segment) 
(O'grady et al., 2011).  
1.10 Laboratory investigation 
According to IDSA guidelines, the semi-quantitative roll plate technique of 5cm catheter 
tip is recommended especially for short term catheter (less than 14 days) and quantitative 
broth culture (luminal flushing or sonication) for catheter which have remained in place 
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for a longer time. However, other studies showed no difference between both approaches 
(Bouza et al., 2005; Mermel et al., 2009).  
In general, detection of >15 colony forming units (CFU) is relevant for roll plate and 
quantitative broth culture (luminal flushing or sonication, positive if >102 CFU are 
detected). However it is less sensitive and unable to culture organisms that embedded 
intraluminal. 
Simultaneous quantitative blood culture drawn through CVC yields CFU count five-fold 
higher or more than CFU count from simultaneously drawn blood from peripheral vein is 
the other methods (Mermel et al., 2009). A meta-analysis study of diagnostic test showed 
that simultaneous quantitative blood culture was found to be the most accurate test for 
diagnosis of CRBSI with pooled sensitivity and specificity 75% and 97% respectively 
(Safdar et al., 2005). However, the use of the simultaneous quantitative blood culture 
technique has been limited because it is labour intensive and expensive 
1.11 Treatment 
There was increasing evidence that antimicrobial lock applied within the catheter lumen 
were effective at preventing CRBSI. Some lock therapy such as citrate, alcohol, ethylene 
diamine triacetic acid (EDTA) has extra antimicrobial and biofilm removing properties. 
On contrast, heparin tends to antagonize the bactericidal properties of certain antibiotic 
like aminoglycosides. Moreover it also promotes biofilm formation unless at very low 
concentrations (Droste et al., 2003; Shanks et al., 2006).  
Heparin catheter lock has become widely used as an antithrombotic agent in catheters 
since two decade ago as a result of studies published between 1979 and 1996 that showed 
heparin infusion effectively reduces catheter-related thrombus formation and may reduce 
catheter infection (Randolph et al., 1998). Several prospective randomised studies have 
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shown that an antimicrobial catheter lock is superior to heparin alone as a lock solution 
in preventing catheter infection (Garland et al., 2002; Henrickson et al., 2000; Safdar et 
al., 2005).  
The choice of antibiotic treatment was depend on individual preference, local or regional 
patterns, and/or recommendations from national or international guidelines. Decision 
whether the CVC should be removed or retained, with antibiotic catheter lock, and the 
duration and type of therapy depend on the type of organism causing the CRBSI. For 
example of coagulase negative staphylococci, catheter removal was once thought to be 
necessary, however almost 80% can be treated with glycopeptide antibiotics, such as 
vancomycin, without catheter removal. However, there is a 20% chance that the 
bacteraemia will recur if the CVC is not removed (Raad and Bodey, 1992). 
According to European Renal Best Practice (ERBP), preference should be given to 
antibiotics with a pharmacokinetic profile allowing administration after each dialysis 
session only (vancomycin, teicoplanin, cefazolin, ceftazidime and daptomycin) 
(Vanholder et al., 2010). In settings where methicillin-resistant S. aureus (MRSA) was 
highly prevalent, vancomycin or teicoplanin was the first choice for empirical treatment 
(Allon, 2003).  
Whereas the duration of therapy for uncomplicated Staphylococcus aureus CRBSI, a 10–
14 day course of intravenous therapy is necessary if the CVC is removed (Dimick et al., 
2001). The type of antibiotics used should be based on the susceptibility of S. aureus. For 
Gram-negative bacteraemia, it is practical to remove the CVC and treat with a 1-week 
course of appropriate susceptible antibiotics. Whereas for candida species, several 
prospective studies have shown that CVC removal was associated with improved in  
patient outcome (Nucci and Anaissie, 2002; Raad et al., 2004). According to IDSA 
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guidelines, the duration of therapy for uncomplicated catheter-related candidaemia should 
be for two weeks duration since from the last positive blood culture (Mermel et al., 2009).  
1.12 Prevention 
It is necessary to minimize CRBSI by monitoring its incidence and to implement 
preventive measures.  More than a decade ago, the bundles were shown to reduce rates of 
CVC related infections. Recent study has demonstrated that consistent application of 
evidence-based practices can lead to significant, sustained reductions in CLABSI rates. 
The implementation of a CVL insertion care bundle was associated with a decrease in the 
total CLABSI/1000 central line days from 14.9 to 11.08 infections as reported by Salama 
et al. (Salama et al., 2016) 
A landmark study in 2006 by Pronovost et al. demonstrated that strict adherence to a 
bundled practice of hand hygiene, full barrier precautions, chlorhexidine skin antisepsis, 
femoral site avoidance, and judicious early line removal can dramatically reduce the rate 
of CRBSI to nearly 0% (Pronovost et al., 2006). 
European Renal Best Practice (ERBP) recommends the preventive measures as 
followings; catheter insertion should be performed under strict aseptic conditions, 
universal precautions and a sterile environment should be applied at any occasion when 
a venous catheter is manipulated, connected or disconnected, practice of antimicrobial 
locks applied within the catheter lumen, and the catheter exit site should be inspected and 
replaced when it is no longer clean (Vanholder et al., 2010). 
Evidence based recommendations for preventing intravascular catheter related infections 
includes 1) educating and training healthcare personnel who insert and maintain catheters; 
2) using maximal sterile barrier precautions during central venous catheter insertion; 3) 
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using a > 0.5% chlorhexidine skin preparation with alcohol for antisepsis and also care 
for maintenance of the catheter.   
The using 2% chlohexidine gluconate in 70% alcohol was more benefit instead of 
povidone-iodine in preventing CRBSI as it was superior and rapid skin decontamination 
(Maki et al., 1991; Mimoz et al., 1996). Indeed, a meta-analysis had shown that daily 
bathing of ICU patients with chlorhexidine gluconate reduces healthcare related infection 
and CRBSI (O'horo et al., 2012).  
Program of "Scrub the Hub," which purpose was to reduce infections, educate, and 
encourage healthcare-workers to disinfect the hub carefully every manipulation, as it had 
been widely practised and recommended. Several institutions have reached their goal of 
eliminating CRBSIs after implementing the same disinfection cap (DeVries et al., 2014). 
As example, DeVries et al., reported that CRBSI rate dropped 43%, comparing the pre-
intervention rate of roughly 0.010/100 patient days to 0.0059/100 patient days during the 
post-intervention period. 
1.13 Mortality of CRBSI 
CRBSI are associated with serious morbidity and mortality. Mortality due to CRBSI is 
difficult to estimate due to multiple confounding factors that can be identified among 
selected patients. Gastmeier et al. estimated that mortality attributable to CRBSI ranges 
from 1000 to 1300 patients per year about 12-15% (Gastmeier et al., 1999). Whereas 
mortality attributable to CRBSI was estimated at 17% by Endimiani et al.(Endimiani et 
al., 2003). The higher rate of 21.8% was reported by a study by Hajjej et al. in Tunisian 
medical ICU (Hajjej et al., 2014). 
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1.14 Rationale of study 
Although there were many studies about CRBSI worldwide but it seem limited study done 
in Malaysia, especially in East-coast of Malaysia (A hospital based study done in 
Malaysia:-UKM Medical Centre, Kuala Lumpur from 2008 to 2009 by Anita et al. 
(Sulong et al., 2011) and a study of incidence and risk factors of CRBSI in ICU of 
Hospital Sultanah Aminah in 2005 by Tan et al. (Tan et al., 2007). 
Therefore the aim of this study was to study the impact of implementation of CVC Care 
Bundle in Hospital USM for prevention of CRBSI. The CVC kit was created and 
introduced to enhance the compliance of practicing this bundle. The incidence rate of 
CRBSI following the implementation of this bundle was analysed and their causative 
microbial agents were described. This intervention was intended for health care personnel 
who inserted and cared for intravascular catheters and who were responsible for the 
surveillance, prevention, and control of infections in all health care settings. Hence, 
intervention aimed at improving outcomes related to CVCs should be seriously 
considered.   
This study could establish a benchmark for comparison with future study in Malaysia and 
for maintenance of CRBSI bundle that was implemented. Apart of that, this could monitor 
performance improvement by documenting and reporting rates of compliance with all 
components of the bundles as benchmark for quality assurance and performance 
improvement. This study would benefit and evoke healthcare workers so that they would 
be more alert to the prevention of CRBSI. We learned that implementation of a CVC Care 
Bundle required not only education, but also engagement of staff and changes in staff 
behaviour. The ultimate goal was to fully integrate the new behaviour into everyday 
practice, which would take some time to implement completely. 
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1.15 Objectives 
1.15.1 General Objectives 
To determine the incidence rate of CRBSI in Hospital USM before and after the 
implementation of CVC Care Bundle. 
 
1.15.2 Specific Objectives 
1  To compare the incidence rate of CRBSI in Hospital USM before and after the 
implementation of CVC Care Bundle. 
2  To identify the etiological agent and its sensitivity pattern of patient with CRBSI. 





2.1 Study design 
This was a cohort study. 
2.2 Study period 
The study was carried out from April 2016 to December 2017. 
2.3 Study location 
The sample was from medical wards, surgical wards and intensive care units in Hospital 
USM. 
2.4 Reference population 
The reference population was all patients with CVC insertion admitted to Hospital USM. 
2.5 Source population 
The source population of this study was defined as patients who fulfil the CRBSI criteria. 
2.6 Study participants 
Patient with CVC inserted on them with various indication that were eligible for data 
record in ward of Hospital USM from April 2017 to December 2017 were recruited in the 
study. 
 
2.7 Inclusion and exclusion criteria 
• Inclusion criteria 
Formatted: Heading 1
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1. Age≥ 18years old 
2. Newly admitted patient for various indication of catheterization  
• Exclusion criteria  
1. Have other central venous access devices 
2.8 Sample size calculation 
Single proportion calculation based on incidence density of CRBSI 
 (The prevalence of CRBSI in Malaysia is around 3.2-9.43 per 1000 catheter days) 
n = (Z / Δ) ² p (1-p) 
   = (1.96/0.05) ² x 9.43 (1-9.43) 
Therefore number of patient involves estimated to be 147. 
2.9 Sampling method 
All patients suspected with CRBSI were recruited. 
2.10 List of variable factors/ Ascertainment (Outcome & Independent variables) 
• Age 
• Sex 
• Site of CVC 
• Length of hospital stay 
• Length of catheter days 
• Duration of CVC 
2.11 Research measurement tool 
CVC Care Bundle checklist included compliance (established checklist by KKM) 
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2.12 Case definition 
A CVC was defined as an intravascular catheter terminating at or close to the heart or in 
a great vessel and used for infusion, withdrawal of blood, or hemodynamic monitoring 
(Horan et al., 2008).  
CRBSI was defined according to Centers for Disease Control and Prevention/National 
Healthcare Safety Network surveillance criteria as bacteremia/fungemia in a patient with 
an intravascular catheter (the line was in use during the 48-hour period before the 
development of the bloodstream infection) with positive blood culture (central and 
peripheral fulfilled requirement based on time to positivity), clinical manifestations of 
infection (ie, fever, chills, and/or hypotension), and no apparent source for the 
bloodstream infection except the catheter (Dimick et al., 2001; Horan, 2004b; Horan et 
al., 2008; O'grady et al., 2011). 
Incidence refers to the occurrence, rate or frequency of disease during a specific period 
in a given specified population (Shields and Twycross, 2003). Incidence of CRBSI is 
estimated by the number of cases per 1000 days of implanted CVCs (Horan, 2004a).  
Total no. of CRBSI cases   x1000 catheter days 
Total no. of catheter days  
CRBSI rate also can be calculated using denominator of cases per 100 admission-days. 
(Control and Prevention, 2017) 
Total no. of admission days of CRBSI cases   x100 admission days 
Total no. of admission days of all patients 
2.13 Pre-intervention 
Pre-intervention study was done from April 2016 to December 2016. Record tracings of 
confirmed cases of CRBSI were done. Patient's clinical data including demographic, co-
morbid illness, clinical manifestations, CVC’s information and clinical outcomes were 
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obtained from clinical notes. The data were analysed and interpreted according to the 
objectives.  
2.14 Intervention 
Intervention study was done from January 2017 to March 2017. The intervention consists 
of: 
1. Implementation of CVC care bundle (insertion and maintenance) 
2. Introduction of CVC kit. 
3. Education and practical session of CRBSI care bundle. 
4. Introduction of CVC care module (video and posters) 
5. Strengthened the audit surveillance for CRBSI based on adopted form by KKM.  
During this intervention period, CVC care bundle based on IDSA guideline 2009 and 
CDC 2011 was implemented (Mermel et al., 2009; O'grady et al., 2011). CVC Care 
Bundle which consists of CVC Insertion Bundle and CVC Maintenance Bundle was 
introduced. The components for CVC Insertion Bundle include proper hand hygiene, 
maximal barrier precautions upon insertion including full body drape, 2% chlorhexidine 
in 70% alcohol solution for skin antisepsis before CVC insertion and daily review of line 
necessity with prompt removal of unnecessary lines. Whereas the components for CVC 
Maintenance Bundle were hand hygiene when accessing, repairing, dressing or any 
manipulation of the IV system, dressing change, scrub the hub with alcohol wipes for 15 
seconds and daily CVC need assessment. 
CVC kit was created and used to enhanced compliance and adherence to the insertion 
bundle. The kit consist of a box which contain of material needed for CVC insertion; 
CVC checklist form, surgical face mask, cap, sterile glove, sterile preparation of 2% 
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chlorhexidine with 70% alcohol, blade, suture, 3 way connector, gauze (op-site), catheter 
lumen, syringe, needle and sterile gown.   
Education regarding this bundle was given. This program involved two days’ workshop 
in two separate occasions. Each workshop was attended by 40-50 participants. The 
participant was healthcare-workers of Hospital USM including medical officers, house 
officers and staff nurses of different wards. The workshops focused on providing 
knowledge on CRBSI and its preventive measures. The education was given in the form 
of 2 hours lectures by clinical microbiologist and followed by practical session on 
insertion and maintenance bundle. The demonstration and practical session on CVC care 
base on CDC guideline in 2009 using mannequin. The staffs were also emphasized on the 
use of checklist as a tool to remind the healthcare-workers of the right thing to do at the 
right time. The education session was given periodically (twice) to teach the nurses and 
doctors who were inserting and taking care of the catheters. 
An educational module was created to aid in implementation of CVC care bundle. This 
module was adopted by MOH based on international Institute for Healthcare 
improvement (Improvement, 2012). The content of the modules includes introduction and 
epidemiology of the subject matter, the surveillance form of insertion and maintenance 
bundle, and the checklist form. Audio visual educational demonstration, manual book 
module and posters were provided for the intervention. 
CVC Insertion Bundle Compliance Checklist Form and CVC Maintenance Bundle 
Compliance Checklist Form were introduced to record the activity. Upon completion of 
CVC insertion, the attending personnel should fill the CVC Insertion Bundle Compliance 
Checklist Form. The attending doctor should review the necessity of continued CVC 
placement for every day. Nurses on duty should chart the indication for continued CVC 
placement whether no longer required in the CVC Maintenance Bundle Compliance 
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Checklist Form. The completed form were send to Unit Kawalan Jangkitan & 
Epidemilogi Hospital USM (UKJEH). 
2.14.1 Application of CVC insertion bundle 
1. Hand hygiene- Hands are decontaminated immediately before and after each 
episode of patient contact using the correct hand hygiene technique. An organized 
approach “5 Moments of Hand Hygiene” will be use. 
2. Use of full barrier precautions/PPE- Maximal sterile barriers and aseptic 
technique, including a sterile gown, sterile gloves, and a large sterile drape, will be use 
for the insertion of a central venous access device. 
3. Chlorhexidine skin antisepsis- A solution of 2% chlorhexidine gluconate in 70% 
isopropyl alcohol is used and allowed to dry for at least 30 seconds. If a patient is sensitive 
to this agent, povidone-iodine application may be used. Aseptic technique is maintained 
throughout insertion of CVCs. 
4. Dressing - A sterile dressing will be apply (gauze and transparent dressing)   
2.14.2 Application of CVC maintenance bundle  
1. Daily review of line necessity with prompt removal of unnecessary CVCs and 
documentation will be conducted. Daily review of the need for CVCs will be done in the 
following ways: 
i. During multidisciplinary patient care rounds or 
ii. By using reminders- stickers on patient records and reminder by staff nurse 
assisting doctor during daily ward round.  
2. Details of removal of CVC will be documented in the records (including date, 
name and signature of the operator undertaking removal) 
